{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T07:36:51Z","timestamp":1773819411794,"version":"3.50.1"},"reference-count":259,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2017,4,8]],"date-time":"2017-04-08T00:00:00Z","timestamp":1491609600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Adenosine triphosphate (ATP)-binding cassette (ABC) transporters are highly expressed in tumor cells, as well as in organs involved in absorption and secretion processes, mediating the ATP-dependent efflux of compounds, both endogenous substances and xenobiotics, including drugs. Their expression and activity levels are modulated by the presence of inhibitors, inducers and\/or activators. In vitro, ex vivo and in vivo studies with both known and newly synthesized P-glycoprotein (P-gp) inducers and\/or activators have shown the usefulness of these transport mechanisms in reducing the systemic exposure and specific tissue access of potentially harmful compounds. This article focuses on the main ABC transporters involved in multidrug resistance [P-gp, multidrug resistance-associated protein 1 (MRP1) and breast cancer resistance protein (BCRP)] expressed in tissues of toxicological relevance, such as the blood-brain barrier, cardiovascular system, liver, kidney and intestine. Moreover, it provides a review of the available cellular models, in vitro and ex vivo assays for the screening and selection of safe and specific inducers and activators of these membrane transporters. The available cellular models and in vitro assays have been proposed as high throughput and low-cost alternatives to excessive animal testing, allowing the evaluation of a large number of compounds.<\/jats:p>","DOI":"10.3390\/molecules22040600","type":"journal-article","created":{"date-parts":[[2017,4,13]],"date-time":"2017-04-13T02:39:17Z","timestamp":1492051157000},"page":"600","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":101,"title":["Cellular Models and In Vitro Assays for the Screening of modulators of P-gp, MRP1 and BCRP"],"prefix":"10.3390","volume":"22","author":[{"given":"Mariline","family":"Gameiro","sequence":"first","affiliation":[{"name":"UCIBIO\/REQUIMTE, Laborat\u00f3rio de Toxicologia, Departamento de Ci\u00eancias Biol\u00f3gicas, Faculdade de Farm\u00e1cia, Universidade do Porto, Rua Jorge Viterbo Ferreira, 228, 4050-313 Porto, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9962-7548","authenticated-orcid":false,"given":"Renata","family":"Silva","sequence":"additional","affiliation":[{"name":"UCIBIO\/REQUIMTE, Laborat\u00f3rio de Toxicologia, Departamento de Ci\u00eancias Biol\u00f3gicas, Faculdade de Farm\u00e1cia, Universidade do Porto, Rua Jorge Viterbo Ferreira, 228, 4050-313 Porto, Portugal"}]},{"given":"Carolina","family":"Rocha-Pereira","sequence":"additional","affiliation":[{"name":"UCIBIO\/REQUIMTE, Laborat\u00f3rio de Toxicologia, Departamento de Ci\u00eancias Biol\u00f3gicas, Faculdade de Farm\u00e1cia, Universidade do Porto, Rua Jorge Viterbo Ferreira, 228, 4050-313 Porto, Portugal"}]},{"given":"Helena","family":"Carmo","sequence":"additional","affiliation":[{"name":"UCIBIO\/REQUIMTE, Laborat\u00f3rio de Toxicologia, Departamento de Ci\u00eancias Biol\u00f3gicas, Faculdade de Farm\u00e1cia, Universidade do Porto, Rua Jorge Viterbo Ferreira, 228, 4050-313 Porto, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3858-3494","authenticated-orcid":false,"given":"F\u00e9lix","family":"Carvalho","sequence":"additional","affiliation":[{"name":"UCIBIO\/REQUIMTE, Laborat\u00f3rio de Toxicologia, Departamento de Ci\u00eancias Biol\u00f3gicas, Faculdade de Farm\u00e1cia, Universidade do Porto, Rua Jorge Viterbo Ferreira, 228, 4050-313 Porto, Portugal"}]},{"given":"Maria","family":"Bastos","sequence":"additional","affiliation":[{"name":"UCIBIO\/REQUIMTE, Laborat\u00f3rio de Toxicologia, Departamento de Ci\u00eancias Biol\u00f3gicas, Faculdade de Farm\u00e1cia, Universidade do Porto, Rua Jorge Viterbo Ferreira, 228, 4050-313 Porto, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1382-5119","authenticated-orcid":false,"given":"Fernando","family":"Remi\u00e3o","sequence":"additional","affiliation":[{"name":"UCIBIO\/REQUIMTE, Laborat\u00f3rio de Toxicologia, Departamento de Ci\u00eancias Biol\u00f3gicas, Faculdade de Farm\u00e1cia, Universidade do Porto, Rua Jorge Viterbo Ferreira, 228, 4050-313 Porto, Portugal"}]}],"member":"1968","published-online":{"date-parts":[[2017,4,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2174\/138920007780655423","article-title":"Evaluation of drug-transporter interactions using in vitro and in vivo models","volume":"8","author":"Xia","year":"2007","journal-title":"Curr. Drug Metab."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1146\/annurev-pharmtox-010611-134529","article-title":"Drug transporters in drug efficacy and toxicity","volume":"52","author":"DeGorter","year":"2012","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2014.11.013","article-title":"Modulation of P-glycoprotein efflux pump: Induction and activation as a therapeutic strategy","volume":"149","author":"Silva","year":"2015","journal-title":"Pharmacol. Ther."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Hesselson, S.E., Matsson, P., Shima, J.E., Fukushima, H., Yee, S.W., Kobayashi, Y., Gow, J.M., Ha, C., Ma, B., and Poon, A. (2009). Genetic variation in the proximal promoter of ABC and SLC superfamilies: Liver and kidney specific expression and promoter activity predict variation. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0006942"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2217\/14622416.9.1.105","article-title":"ABC multidrug transporters: Structure, function and role in chemoresistance","volume":"9","author":"Sharom","year":"2008","journal-title":"Pharmacogenomics"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1124\/jpet.107.132225","article-title":"The role of ATP binding cassette transporters in tissue defense and organ regeneration","volume":"328","author":"Huls","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.taap.2004.10.012","article-title":"Multidrug resistance proteins: Role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense","volume":"204","author":"Leslie","year":"2005","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1146\/annurev-pharmtox-010611-134609","article-title":"Cyclic nucleotide compartmentalization: Contributions of phosphodiesterases and ATP-binding cassette transporters","volume":"53","author":"Cheepala","year":"2013","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1016\/j.jacc.2013.02.058","article-title":"The P-glycoprotein transport system and cardiovascular drugs","volume":"61","author":"Wessler","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.addr.2012.09.042","article-title":"Intestinal drug transporters: An overview","volume":"65","author":"Estudante","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3109\/03602532.2014.882353","article-title":"Phase 0 and phase III transport in various organs: Combined concept of phases in xenobiotic transport and metabolism","volume":"46","author":"Doring","year":"2014","journal-title":"Drug Metab. Rev."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"843","DOI":"10.2174\/1568026611313070007","article-title":"Molecular modeling and ligand docking for solute carrier (SLC) transporters","volume":"13","author":"Schlessinger","year":"2013","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.cell.2015.07.022","article-title":"A call for systematic research on solute carriers","volume":"162","author":"Snijder","year":"2015","journal-title":"Cell"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1124\/pr.58.2.7","article-title":"The ATP-binding cassette transporters and their implication in drug disposition: A special look at the heart","volume":"58","author":"Couture","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.freeradbiomed.2006.06.012","article-title":"P-glycoprotein induction: An antidotal pathway for paraquat-induced lung toxicity","volume":"41","author":"Remiao","year":"2006","journal-title":"Free Radic. Biol. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s00204-010-0587-8","article-title":"In vitro study of P-glycoprotein induction as an antidotal pathway to prevent cytotoxicity in Caco-2 cells","volume":"85","author":"Silva","year":"2011","journal-title":"Arch. Toxicol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.2174\/092986712800167392","article-title":"Three decades of P-gp inhibitors: Skimming through several generations and scaffolds","volume":"19","author":"Palmeira","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.bcp.2011.10.004","article-title":"Dual inhibitors of P-glycoprotein and tumor cell growth: (Re)discovering thioxanthones","volume":"83","author":"Palmeira","year":"2012","journal-title":"Biochem. Pharmacol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.toxlet.2012.11.028","article-title":"Doxorubicin decreases paraquat accumulation and toxicity in Caco-2 cells","volume":"217","author":"Silva","year":"2013","journal-title":"Toxicol. Lett."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Vilas-Boas, V., Silva, R., Palmeira, A., Sousa, E., Ferreira, L.M., Branco, P.S., Carvalho, F., Bastos Mde, L., and Remiao, F. (2013). Development of novel rifampicin-derived P-glycoprotein activators\/inducers. Synthesis, in silico analysis and application in the RBE4 cell model, using paraquat as substrate. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0074425"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1007\/s00204-014-1193-y","article-title":"Induction and activation of P-glycoprotein by dihydroxylated xanthones protect against the cytotoxicity of the P-glycoprotein substrate paraquat","volume":"88","author":"Silva","year":"2014","journal-title":"Arch. Toxicol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1007\/s00204-014-1333-4","article-title":"P-glycoprotein induction in Caco-2 cells by newly synthetized thioxanthones prevents paraquat cytotoxicity","volume":"89","author":"Silva","year":"2015","journal-title":"Arch. Toxicol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1002\/cmdc.201000216","article-title":"Specific inhibitors of the breast cancer resistance protein (BCRP)","volume":"5","author":"Pick","year":"2010","journal-title":"ChemMedChem"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"4197","DOI":"10.2174\/138161212802430530","article-title":"Structure and ligand-based design of P-glycoprotein inhibitors: A historical perspective","volume":"18","author":"Palmeira","year":"2012","journal-title":"Curr. Pharm. Des."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.drup.2012.01.005","article-title":"Tyrosine kinase inhibitors as modulators of ABC transporter-mediated drug resistance","volume":"15","author":"Shukla","year":"2012","journal-title":"Drug Resist. Updates"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s13346-016-0353-4","article-title":"A novel mechanism governing the transcriptional regulation of ABC transporters in MDR cancer cells","volume":"7","author":"Lu","year":"2017","journal-title":"Drug Deliv. Transl. Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1023\/A:1012823120935","article-title":"Complete characterization of the human ABC gene family","volume":"33","author":"Dean","year":"2001","journal-title":"J. Bioenerg. Biomembr."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1186\/1479-7364-3-3-281","article-title":"Human ATP-binding cassette (ABC) transporter family","volume":"3","author":"Vasiliou","year":"2009","journal-title":"Hum. Genom."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1038\/nsmb836","article-title":"The ATP switch model for ABC transporters","volume":"11","author":"Higgins","year":"2004","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1152\/physiol.00046.2006","article-title":"Structure and function of ABC transporters","volume":"22","author":"Linton","year":"2007","journal-title":"Physiology"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s00424-006-0126-x","article-title":"Structure and function of ABC transporters: The ATP switch provides flexible control","volume":"453","author":"Linton","year":"2007","journal-title":"Pflugers Archiv Eur. J. Physiol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.addr.2008.09.007","article-title":"Ins and outs of the ABCG2 multidrug transporter: An update on in vitro functional assays","volume":"61","author":"Hegedus","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.bbapap.2008.12.004","article-title":"Molecular basis of multidrug transport by ABC transporters","volume":"1794","author":"Seeger","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"7104","DOI":"10.1074\/jbc.M110.201178","article-title":"Asymmetric ATP hydrolysis cycle of the heterodimeric multidrug ABC transport complex TmrAB from Thermus thermophilus","volume":"286","author":"Zutz","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1747-0285.2011.01089.x","article-title":"New uses for old drugs: Pharmacophore-based screening for the discovery of P-glycoprotein inhibitors","volume":"78","author":"Palmeira","year":"2011","journal-title":"Chem. Biol. Drug Des."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1126\/science.1168750","article-title":"Structure of P-Glycoprotein reveals a molecular basis for poly-specific drug binding","volume":"323","author":"Aller","year":"2009","journal-title":"Science"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.jmb.2006.04.005","article-title":"Structure of the Human Multidrug Resistance Protein 1 Nucleotide Binding Domain 1 bound to Mg2+\/ATP Reveals a Non-productive Catalytic Site","volume":"359","author":"Ramaen","year":"2006","journal-title":"J. Mol. Biol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1432-1033.1997.00130.x","article-title":"Positively cooperative sites for drug transport by P-glycoprotein with distinct drug specificities","volume":"250","author":"Shapiro","year":"1997","journal-title":"Eur. J. Biochem."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1046\/j.1432-1327.1999.00098.x","article-title":"Stimulation of P-glycoprotein-mediated drug transport by prazosin and progesterone. Evidence for a third drug-binding site","volume":"259","author":"Shapiro","year":"1999","journal-title":"Eur. J. Biochem."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1124\/mol.58.3.624","article-title":"Communication between multiple drug binding sites on P-glycoprotein","volume":"58","author":"Martin","year":"2000","journal-title":"Mol. Pharmacol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"12324","DOI":"10.1074\/jbc.M009782200","article-title":"Major photoaffinity drug binding sites in multidrug resistance protein 1 (MRP1) are within transmembrane domains 10\u201311 and 16\u201317","volume":"276","author":"Daoud","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"15344","DOI":"10.1021\/bi0020574","article-title":"Rhodamine 123 binds to multiple sites in the multidrug resistance protein (MRP1)","volume":"39","author":"Daoud","year":"2000","journal-title":"Biochemistry"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jsb.2007.12.001","article-title":"Homology modeling of breast cancer resistance protein (ABCG2)","volume":"162","author":"Hazai","year":"2008","journal-title":"J. Struct. Biol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"115","DOI":"10.4103\/1817-1737.98842","article-title":"Role of ATP binding and hydrolysis in the gating of the cystic fibrosis transmembrane conductance regulator","volume":"7","author":"Gout","year":"2012","journal-title":"Ann. Thorac. Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.bcp.2005.06.018","article-title":"Expression of the drug transporters MDR1\/ABCB1, MRP1\/ABCC1, MRP2\/ABCC2, BCRP\/ABCG2, and PXR in peripheral blood mononuclear cells and their relationship with the expression in intestine and liver","volume":"70","author":"Albermann","year":"2005","journal-title":"Biochem. Pharmacol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1146\/annurev.pharmtox.44.101802.121444","article-title":"Evaluation of drug-drug interaction in the hepatobiliary and renal transport of drugs","volume":"45","author":"Shitara","year":"2005","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.mam.2012.10.012","article-title":"Transporter biology in drug approval: Regulatory aspects","volume":"34","author":"Maeda","year":"2013","journal-title":"Mol. Asp. Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.toxlet.2012.11.011","article-title":"The role of efflux transporters on the transport of highly toxic aconitine, mesaconitine, hypaconitine, and their hydrolysates, as determined in cultured Caco-2 and transfected MDCKII cells","volume":"216","author":"Ye","year":"2013","journal-title":"Toxicol. Lett."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1023\/A:1012866803188","article-title":"Overview: ABC transporters and human disease","volume":"33","author":"Gottesman","year":"2001","journal-title":"J. Bioenerg. Biomembr."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1080\/00498250701867889","article-title":"Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition","volume":"38","author":"Zhou","year":"2008","journal-title":"Xenobiotica"},{"key":"ref_51","first-page":"305","article-title":"Role of multidrug resistance associated proteins in drug development","volume":"2","author":"Zhou","year":"2008","journal-title":"Drug Discov. Ther."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1081\/DMR-120001389","article-title":"Drugs as P-glycoprotein substrates, inhibitors, and inducers","volume":"34","author":"Kim","year":"2002","journal-title":"Drug Metab. Rev."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1006\/bbrc.2002.6367","article-title":"Induction of multidrug resistance proteins MRP1 and MRP3 and gamma-glutamylcysteine synthetase gene expression by nonsteroidal anti-inflammatory drugs in human colon cancer cells","volume":"290","author":"Tatebe","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.2174\/138161208784746798","article-title":"Clinical drugs that interact with St. John\u2019s wort and implication in drug development","volume":"14","author":"Di","year":"2008","journal-title":"Curr. Pharm. Des."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.bcp.2008.07.020","article-title":"Induction of P-glycoprotein expression and function in human intestinal epithelial cells (T84)","volume":"76","author":"Haslam","year":"2008","journal-title":"Biochem. Pharmacol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.tips.2010.03.003","article-title":"Regulation of P-glycoprotein and other ABC drug transporters at the blood-brain barrier","volume":"31","author":"Miller","year":"2010","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.ejps.2012.06.011","article-title":"PXR and NF-\u03baB correlate with the inducing effects of IL-1\u03b2 and TNF-\u03b1 on ABCG2 expression in breast cancer cell lines","volume":"47","author":"Malekshah","year":"2012","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1002\/cmdc.200900283","article-title":"Activators of P-glycoprotein: Structure-activity relationships and investigation of their mode of action","volume":"4","author":"Sterz","year":"2009","journal-title":"ChemMedChem"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.tox.2006.07.025","article-title":"Single high dose dexamethasone treatment decreases the pathological score and increases the survival rate of paraquat-intoxicated rats","volume":"227","author":"Duarte","year":"2006","journal-title":"Toxicology"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"S317","DOI":"10.1016\/j.toxlet.2015.08.905","article-title":"Hypericin-mediated P-glycoprotein induction protects caco-2 cells against paraquat toxicity: In vitro and in silico studies","volume":"238","author":"Silva","year":"2015","journal-title":"Toxicol. Lett."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.tox.2014.03.007","article-title":"Regulation of expression and activity of multidrug resistance proteins MRP2 and MDR1 by estrogenic compounds in Caco-2 cells. Role in prevention of xenobiotic-induced cytotoxicity","volume":"320","author":"Arias","year":"2014","journal-title":"Toxicology"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.toxlet.2011.10.019","article-title":"Protective effect of methylprednisolone on paraquat-induced A549 cell cytotoxicity via induction of efflux transporter, P-glycoprotein expression","volume":"208","author":"Zerin","year":"2012","journal-title":"Toxicol. Lett."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.tips.2013.09.001","article-title":"Protection against chemotherapy-induced alopecia: Targeting ATP-binding cassette transporters in the hair follicle?","volume":"34","author":"Haslam","year":"2013","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1111\/bjd.13549","article-title":"Differential expression and functionality of ATP-binding cassette transporters in the human hair follicle","volume":"172","author":"Haslam","year":"2015","journal-title":"Br. J. Dermatol."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"DeStefano, G.M., Kurban, M., Anyane-Yeboa, K., Dall\u2019Armi, C., Di Paolo, G., Feenstra, H., Silverberg, N., Rohena, L., Lopez-Cepeda, L.D., and Jobanputra, V. (2014). Mutations in the cholesterol transporter gene ABCA5 are associated with excessive hair overgrowth. PLoS Genet., 10.","DOI":"10.1371\/journal.pgen.1004333"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1021\/jm900743c","article-title":"Perspectives of P-glycoprotein modulating agents in oncology and neurodegenerative diseases: Pharmaceutical, biological, and diagnostic potentials","volume":"53","author":"Colabufo","year":"2010","journal-title":"J. Med. Chem."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.2174\/138161211797440122","article-title":"Blood-brain barrier P-glycoprotein function in neurodegenerative disease","volume":"17","author":"Bartels","year":"2011","journal-title":"Curr. Pharm. Des."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"615","DOI":"10.2174\/1567205013666160314151012","article-title":"A Role for P-Glycoprotein in Clearance of Alzheimer Amyloid \u03b2-Peptide from the Brain","volume":"13","author":"Wang","year":"2016","journal-title":"Curr. Alzheimer Res."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s12192-014-0566-8","article-title":"Evidence against a role of P-glycoprotein in the clearance of the Alzheimer\u2019s disease Abeta1\u201342 peptides","volume":"20","author":"Bello","year":"2015","journal-title":"Cell Stress Chaperones"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neuron.2008.01.003","article-title":"The blood-brain barrier in health and chronic neurodegenerative disorders","volume":"57","author":"Zlokovic","year":"2008","journal-title":"Neuron"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"e1299","DOI":"10.1038\/cddis.2014.258","article-title":"A\u03b21\u201342 reduces P-glycoprotein in the blood-brain barrier through RAGE-NF-\u03baB signaling","volume":"5","author":"Park","year":"2014","journal-title":"Cell Death Dis."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.nbd.2014.04.001","article-title":"Alzheimer\u2019s and ABC transporters\u2014New opportunities for diagnostics and treatment","volume":"72 Pt A","author":"Pahnke","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1016\/j.neurobiolaging.2015.05.020","article-title":"P-glycoprotein expression and amyloid accumulation in human aging and Alzheimer\u2019s disease: Preliminary observations","volume":"36","author":"Chiu","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.2174\/138161211797440168","article-title":"The role of the ATP-binding cassette transporter P-glycoprotein in the transport of beta-amyloid across the blood-brain barrier","volume":"17","author":"Vogelgesang","year":"2011","journal-title":"Curr. Pharm. Des."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/clpt.2010.126","article-title":"MDR1-P-glycoprotein (ABCB1)-mediated disposition of amyloid-beta peptides: Implications for the pathogenesis and therapy of Alzheimer\u2019s disease","volume":"88","author":"Jedlitschky","year":"2010","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/00008571-200210000-00005","article-title":"Deposition of Alzheimer\u2019s \u03b2-amyloid is inversely correlated with P-glycoprotein expression in the brains of elderly non-demented humans","volume":"12","author":"Vogelgesang","year":"2002","journal-title":"Pharmacogenetics"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1172\/JCI25247","article-title":"P-glycoprotein deficiency at the blood-brain barrier increases amyloid-\u03b2 deposition in an Alzheimer disease mouse model","volume":"115","author":"Cirrito","year":"2005","journal-title":"J. Clin. Investig."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"5808","DOI":"10.2174\/1381612822666160804094544","article-title":"Blood-Brain Barrier ABC-transporter P-glycoprotein in Alzheimer\u2019s Disease: Still a Suspect?","volume":"22","year":"2016","journal-title":"Curr. Pharm. Des."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1111\/j.2042-7158.2011.01309.x","article-title":"Up-regulation of P-glycoprotein reduces intracellular accumulation of beta amyloid: Investigation of P-glycoprotein as a novel therapeutic target for Alzheimer\u2019s disease","volume":"63","author":"Abuznait","year":"2011","journal-title":"J. Pharm. Pharmacol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"5463","DOI":"10.1523\/JNEUROSCI.5103-08.2009","article-title":"ABCG2 is upregulated in Alzheimer\u2019s brain with cerebral amyloid angiopathy and may act as a gatekeeper at the blood-brain barrier for A\u03b21\u201340 peptides","volume":"29","author":"Xiong","year":"2009","journal-title":"J. Neurosci."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.tiv.2007.07.007","article-title":"Use of Z310 cells as an in vitro blood-cerebrospinal fluid barrier model: Tight junction proteins and transport properties","volume":"22","author":"Shi","year":"2008","journal-title":"Toxicol. In Vitro"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"3900","DOI":"10.1073\/pnas.96.7.3900","article-title":"Choroid plexus epithelial expression of MDR1 P glycoprotein and multidrug resistance-associated protein contribute to the blood-cerebrospinal-fluid drug-permeability barrier","volume":"96","author":"Rao","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1532-5415.2004.52109.x","article-title":"A randomized, controlled trial of doxycycline and rifampin for patients with Alzheimer\u2019s disease","volume":"52","author":"Loeb","year":"2004","journal-title":"J. Am. Geriatr. Soc."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2015.10.049","article-title":"Discovery of a marine-derived bis-indole alkaloid fascaplysin, as a new class of potent P-glycoprotein inducer and establishment of its structure-activity relationship","volume":"107","author":"Manda","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ejmech.2016.07.005","article-title":"Functional induction of P-glycoprotein efflux pump by phenyl benzenesulfonamides: Synthesis and biological evaluation of T0901317 analogs","volume":"122","author":"Padala","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.2174\/156802610792928022","article-title":"Substrates, inhibitors and activators of P-glycoprotein: Candidates for radiolabeling and imaging perspectives","volume":"10","author":"Colabufo","year":"2010","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/cmdc.201100469","article-title":"A benzopyrane derivative as a P-glycoprotein stimulator: A potential agent to decrease beta-amyloid accumulation in Alzheimer\u2019s disease","volume":"7","author":"Contino","year":"2012","journal-title":"ChemMedChem"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"e4982","DOI":"10.1097\/MD.0000000000004982","article-title":"Genetic association of NOS1 exon18, NOS1 exon29, ABCB1 1236C\/T, and ABCB1 3435C\/T polymorphisms with the risk of Parkinson\u2019s disease: A meta-analysis","volume":"95","author":"Huang","year":"2016","journal-title":"Medicine"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.peptides.2014.09.018","article-title":"Alpha synuclein is transported into and out of the brain by the blood-brain barrier","volume":"62","author":"Sui","year":"2014","journal-title":"Peptides"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.parkreldis.2008.11.010","article-title":"Association of a polymorphism in the ABCB1 gene with Parkinson\u2019s disease","volume":"15","author":"Westerlund","year":"2009","journal-title":"Parkinsonism Relat. Disord."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.neulet.2004.09.046","article-title":"Analysis of MDR1 haplotypes in Parkinson\u2019s disease in a white population","volume":"372","author":"Tan","year":"2004","journal-title":"Neurosci. Lett."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S0169-409X(02)00064-9","article-title":"The influence of MDR1 polymorphisms on P-glycoprotein expression and function in humans","volume":"54","author":"Fromm","year":"2002","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.clpt.2003.09.012","article-title":"Polymorphisms in human MDR1 (P-glycoprotein): Recent advances and clinical relevance","volume":"75","author":"Marzolini","year":"2004","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Liu, Q., Hou, J., Chen, X., Liu, G., Zhang, D., Sun, H., and Zhang, J. (2014). P-glycoprotein mediated efflux limits the transport of the novel anti-Parkinson\u2019s disease candidate drug FLZ across the physiological and PD pathological in vitro BBB models. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0102442"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"5779","DOI":"10.2174\/1381612822666160810123634","article-title":"PET Tracers for Imaging of ABC Transporters at the Blood-Brain Barrier: Principles and Strategies","volume":"22","author":"Luurtsema","year":"2016","journal-title":"Curr. Pharm. Des."},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Hartz, A.M., Pekcec, A., Soldner, E.L., Zhong, Y., Schlichtiger, J., and Bauer, B. (2017). P-gp protein expression and transport activity in rodent seizure models and human epilepsy. Mol. Pharm.","DOI":"10.1021\/acs.molpharmaceut.6b00770"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.biomaterials.2015.10.050","article-title":"A multimodal Pepstatin A peptide-based nanoagent for the molecular imaging of P-glycoprotein in the brains of epilepsy rats","volume":"76","author":"Yu","year":"2016","journal-title":"Biomaterials"},{"key":"ref_98","first-page":"1","article-title":"New anticancer agents: In vitro and in vivo evaluation","volume":"19","author":"Zips","year":"2005","journal-title":"In Vivo"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1602\/neurorx.2.1.86","article-title":"Blood-brain barrier active efflux transporters: ATP-binding cassette gene family","volume":"2","author":"Loscher","year":"2005","journal-title":"NeuroRx"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"311","DOI":"10.31887\/DCNS.2006.8.3\/fgirardin","article-title":"Membrane transporter proteins: A challenge for CNS drug development","volume":"8","author":"Girardin","year":"2006","journal-title":"Dialogues Clin. Neurosci."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.2174\/138161211797440186","article-title":"Breast cancer resistance protein and P-glycoprotein in brain cancer: Two gatekeepers team up","volume":"17","author":"Agarwal","year":"2011","journal-title":"Curr. Pharm. Des."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0169-409X(02)00172-2","article-title":"Drug efflux transporters in the CNS","volume":"55","author":"Sun","year":"2003","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1177\/1073858410391270","article-title":"ATP-binding cassette transporters and their roles in protecting the brain","volume":"17","author":"ElAli","year":"2011","journal-title":"Neuroscientist"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0006-8993(00)02628-7","article-title":"Expression of various multidrug resistance-associated protein (MRP) homologues in brain microvessel endothelial cells","volume":"876","author":"Zhang","year":"2000","journal-title":"Brain Res."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1124\/mol.58.6.1357","article-title":"Xenobiotic transport across isolated brain microvessels studied by confocal microscopy","volume":"58","author":"Miller","year":"2000","journal-title":"Mol. Pharmacol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1046\/j.1528-1157.2001.12301.x","article-title":"Overexpression of multiple drug resistance genes in endothelial cells from patients with refractory epilepsy","volume":"42","author":"Dombrowski","year":"2001","journal-title":"Epilepsia"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"732","DOI":"10.2174\/138920011798357024","article-title":"Interplay of drug metabolizing CYP450 enzymes and ABC transporters in the blood-brain barrier","volume":"12","author":"Decleves","year":"2011","journal-title":"Curr. Drug Metab."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"113","DOI":"10.55782\/ane-2011-1828","article-title":"In vitro models of the blood-brain barrier","volume":"71","author":"Wilhelm","year":"2011","journal-title":"Acta Neurobiol. Exp."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.2174\/13816128113199990466","article-title":"Human ABC transporters at blood-CNS interfaces as determinants of CNS drug penetration","volume":"20","author":"Chaves","year":"2014","journal-title":"Curr. Pharm. Des."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1002\/jps.23022","article-title":"In vitro blood-brain barrier models: Current and perspective technologies","volume":"101","author":"Naik","year":"2012","journal-title":"J. Pharm. Sci."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1111\/j.1471-4159.2008.05730.x","article-title":"The human brain endothelial cell line hCMEC\/D3 as a human blood-brain barrier model for drug transport studies","volume":"107","author":"Poller","year":"2008","journal-title":"J. Neurochem."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/2045-8118-10-33","article-title":"Comparative study of four immortalized human brain capillary endothelial cell lines, hCMEC\/D3, hBMEC, TY10, and BB19, and optimization of culture conditions, for an in vitro blood-brain barrier model for drug permeability studies","volume":"10","author":"Eigenmann","year":"2013","journal-title":"Fluids Barriers CNS"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1096\/fj.04-3458fje","article-title":"Blood-brain barrier-specific properties of a human adult brain endothelial cell line","volume":"19","author":"Weksler","year":"2005","journal-title":"FASEB J."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1021\/mp3004308","article-title":"Quantitative targeted absolute proteomic analysis of transporters, receptors and junction proteins for validation of human cerebral microvascular endothelial cell line hCMEC\/D3 as a human blood-brain barrier model","volume":"10","author":"Ohtsuki","year":"2013","journal-title":"Mol. Pharm."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/2045-8118-10-16","article-title":"The hCMEC\/D3 cell line as a model of the human blood brain barrier","volume":"10","author":"Weksler","year":"2013","journal-title":"Fluids Barriers CNS"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.bcp.2008.11.001","article-title":"Expression and transcriptional regulation of ABC transporters and cytochromes P450 in hCMEC\/D3 human cerebral microvascular endothelial cells","volume":"77","author":"Dauchy","year":"2009","journal-title":"Biochem. Pharmacol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00441-006-0348-4","article-title":"NKIM-6, a new immortalized human brain capillary endothelial cell line with conserved endothelial characteristics","volume":"328","author":"Kashfi","year":"2007","journal-title":"Cell Tissue Res."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/jcp.22232","article-title":"Establishment of a new conditionally immortalized human brain microvascular endothelial cell line retaining an in vivo blood-brain barrier function","volume":"225","author":"Sano","year":"2010","journal-title":"J. Cell. Physiol."},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Wassmer, S.C., Cianciolo, G.J., Combes, V., and Grau, G.E. (2005). Inhibition of endothelial activation: A new way to treat cerebral malaria?. PLoS Med., 2.","DOI":"10.1371\/journal.pmed.0020245"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-0186(85)90002-6","article-title":"The blood-brain barrier in vitro: Ten years of research on microvessels isolated from the brain","volume":"7","author":"Joo","year":"1985","journal-title":"Neurochem. Int."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1021\/cn4002329","article-title":"Reversible dimers of the atypical antipsychotic quetiapine inhibit P-glycoprotein-mediated efflux in vitro with increased binding affinity and in situ at the blood-brain barrier","volume":"5","author":"Emmert","year":"2014","journal-title":"ACS Chem. Neurosci."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1124\/jpet.114.218180","article-title":"Glutamate-mediated upregulation of the multidrug resistance protein 2 in porcine and human brain capillaries","volume":"352","author":"Salvamoser","year":"2015","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s00401-014-1244-8","article-title":"P-glycoprotein regulates trafficking of CD8(+) T cells to the brain parenchyma","volume":"127","author":"Kooij","year":"2014","journal-title":"Acta Neuropathol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.tcm.2005.10.001","article-title":"ATP-binding cassette transporters in the heart","volume":"16","author":"Solbach","year":"2006","journal-title":"Trends Cardiovasc. Med."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1177\/002215540205001008","article-title":"Expression and localization of P-glycoprotein in human heart: Effects of cardiomyopathy","volume":"50","author":"Meissner","year":"2002","journal-title":"J. Histochem. Cytochem."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1369\/jhc.5A6750.2005","article-title":"The ATP-binding cassette transporter ABCG2 (BCRP), a marker for side population stem cells, is expressed in human heart","volume":"54","author":"Meissner","year":"2006","journal-title":"J. Histochem. Cytochem."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1161\/01.CIR.99.4.552","article-title":"Inhibition of P-glycoprotein-mediated drug transport: A unifying mechanism to explain the interaction between digoxin and quinidine","volume":"99","author":"Fromm","year":"1999","journal-title":"Circulation"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1042\/bj3260539","article-title":"P-glycoprotein is strongly expressed in the luminal membranes of the endothelium of blood vessels in the brain","volume":"326 Pt. 2","author":"Beaulieu","year":"1997","journal-title":"Biochem. J."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0887-2333(99)00087-9","article-title":"Effect of PSC 833, verapamil and amiodarone on adriamycin toxicity in cultured rat cardiomyocytes","volume":"14","author":"Estevez","year":"2000","journal-title":"Toxicology In Vitro"},{"key":"ref_130","first-page":"1237","article-title":"Tissue distribution of the multidrug resistance protein","volume":"148","author":"Flens","year":"1996","journal-title":"Am. J. Pathol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1046\/j.1440-169X.2003.00699.x","article-title":"Physiological regulation of P-glycoprotein, MRP1, MRP2 and cytochrome P450 3A2 during rat ontogeny","volume":"45","author":"Rosati","year":"2003","journal-title":"Dev. Growth Differ."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/S0002-9440(10)63513-4","article-title":"Expression and localization of the multidrug resistance protein 5 (MRP5\/ABCC5), a cellular export pump for cyclic nucleotides, in human heart","volume":"163","author":"Dazert","year":"2003","journal-title":"Am. J. Pathol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2133\/dmpk.19.135","article-title":"Tissue-specific mRNA expression profiles of human nuclear receptor subfamilies","volume":"19","author":"Nishimura","year":"2004","journal-title":"Drug Metab. Pharmacokinet."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1111\/j.1528-1167.2005.66604.x","article-title":"Localization of breast cancer resistance protein (BCRP) in microvessel endothelium of human control and epileptic brain","volume":"46","author":"Aronica","year":"2005","journal-title":"Epilepsia"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1007\/s11095-016-2028-8","article-title":"Placental ABC Transporters: Biological Impact and Pharmaceutical Significance","volume":"33","author":"Joshi","year":"2016","journal-title":"Pharm. Res."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1007\/s11095-008-9537-z","article-title":"BCRP\/ABCG2 in the placenta: Expression, function and regulation","volume":"25","author":"Mao","year":"2008","journal-title":"Pharm. Res."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.ydbio.2003.09.028","article-title":"Persistent expression of the ATP-binding cassette transporter, Abcg2, identifies cardiac SP cells in the developing and adult heart","volume":"265","author":"Martin","year":"2004","journal-title":"Dev. Biol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.3181\/0802-RM-59","article-title":"MRP (ABCC) transporters-mediated efflux of anti-HIV drugs, saquinavir and zidovudine, from human endothelial cells","volume":"233","author":"Eilers","year":"2008","journal-title":"Exp. Biol. Med."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1161\/ATVBAHA.111.240341","article-title":"The ATP-binding cassette transporter ABCG2 protects against pressure overload-induced cardiac hypertrophy and heart failure by promoting angiogenesis and antioxidant response","volume":"32","author":"Higashikuni","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/clpt.2012.79","article-title":"A perspective on efflux transport proteins in the liver","volume":"92","author":"Kock","year":"2012","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.2174\/092986708785132870","article-title":"Substrates and inhibitors of human multidrug resistance associated proteins and the implications in drug development","volume":"15","author":"Zhou","year":"2008","journal-title":"Curr. Med. Chem."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"4904","DOI":"10.2741\/3576","article-title":"Hepatobiliary ABC transporters: Physiology, regulation and implications for disease","volume":"14","author":"Jonker","year":"2009","journal-title":"Front. Biosci."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.2217\/pgs.11.44","article-title":"Transporter-mediated drug-drug interactions","volume":"12","author":"Muller","year":"2011","journal-title":"Pharmacogenomics"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1046\/j.1523-1755.2000.00251.x","article-title":"Cellular and molecular aspects of drug transport in the kidney","volume":"58","author":"Inui","year":"2000","journal-title":"Kidney Int."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"7068","DOI":"10.3748\/wjg.14.7068","article-title":"Hepatic drug transporters and nuclear receptors: Regulation by therapeutic agents","volume":"14","author":"Mottino","year":"2008","journal-title":"World J. Gastroenterol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1055\/s-2000-9388","article-title":"Intracellular trafficking and regulation of canalicular ATP-binding cassette transporters","volume":"20","author":"Kipp","year":"2000","journal-title":"Semin. Liver Dis."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/clpt.2009.235","article-title":"Drug uptake systems in liver and kidney: A historic perspective","volume":"87","author":"Hagenbuch","year":"2010","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2174\/1389200033489460","article-title":"Drug uptake systems in liver and kidney","volume":"4","author":"Hagenbuch","year":"2003","journal-title":"Curr. Drug Metab."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(02)00169-2","article-title":"Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: An overview","volume":"55","author":"Schinkel","year":"2003","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ejps.2006.01.004","article-title":"Functional expression of sinusoidal and canalicular hepatic drug transporters in the differentiated human hepatoma HepaRG cell line","volume":"28","author":"Jigorel","year":"2006","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.ejps.2005.12.007","article-title":"Integration of hepatic drug transporters and phase II metabolizing enzymes: Mechanisms of hepatic excretion of sulfate, glucuronide, and glutathione metabolites","volume":"27","author":"Hoffmaster","year":"2006","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1517\/17425255.4.4.363","article-title":"The role of hepatic transporters in drug elimination","volume":"4","author":"Funk","year":"2008","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1124\/dmd.113.054528","article-title":"Functional ATP-binding cassette drug efflux transporters in isolated human and rat hepatocytes significantly affect assessment of drug disposition","volume":"42","author":"Lundquist","year":"2014","journal-title":"Drug Metab. Dispos."},{"key":"ref_154","doi-asserted-by":"crossref","unstructured":"Fromm, M.F., and Kim, R.B. (2011). In vitro and in vivo evidence for the importance of breast cancer resistance protein transporters (BCRP\/MXR\/ABCP\/ABCG2). Drug Transporters, Springer.","DOI":"10.1007\/978-3-642-14541-4"},{"key":"ref_155","doi-asserted-by":"crossref","unstructured":"Fromm, M.F., and Kim, R.B. (2011). Organic cation transporters (OCTs, MATEs), in vitro and in vivo evidence for the importance in drug therapy. Drug Transporters, Springer.","DOI":"10.1007\/978-3-642-14541-4"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1039\/C2TX20051A","article-title":"In vitro models for liver toxicity testing","volume":"2","author":"Soldatow","year":"2013","journal-title":"Toxicol. Res."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-60761-688-7_1","article-title":"General review on in vitro hepatocyte models and their applications","volume":"640","author":"Guillouzo","year":"2010","journal-title":"Methods Mol. Biol."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1124\/dmd.105.006759","article-title":"Expression of cytochromes P450, conjugating enzymes and nuclear receptors in human hepatoma HepaRG cells","volume":"34","author":"Aninat","year":"2006","journal-title":"Drug Metab. Dispos."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"15655","DOI":"10.1073\/pnas.232137699","article-title":"Infection of a human hepatoma cell line by hepatitis B virus","volume":"99","author":"Gripon","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.cbi.2006.12.003","article-title":"The human hepatoma HepaRG cells: A highly differentiated model for studies of liver metabolism and toxicity of xenobiotics","volume":"168","author":"Guillouzo","year":"2007","journal-title":"Chem. Biol. Interact."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1042\/BC20070127","article-title":"Which in vitro models could be best used to study hepatocyte polarity?","volume":"100","author":"Decaens","year":"2008","journal-title":"Biol. Cell"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1124\/dmd.107.020016","article-title":"Evaluation of HepaRG cells as an in vitro model for human drug metabolism studies","volume":"36","author":"Kanebratt","year":"2008","journal-title":"Drug Metab. Dispos."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/978-1-4899-1863-5_9","article-title":"Cultured rat hepatocytes","volume":"8","author":"LeCluyse","year":"1996","journal-title":"Pharm. Biotechnol."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1096\/fasebj.3.2.2914628","article-title":"Hepatocyte function and extracellular matrix geometry: Long-term culture in a sandwich configuration","volume":"3","author":"Dunn","year":"1989","journal-title":"FASEB J."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1021\/bp00009a007","article-title":"Long-term in vitro function of adult hepatocytes in a collagen sandwich configuration","volume":"7","author":"Dunn","year":"1991","journal-title":"Biotechnol. Prog."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"446","DOI":"10.3109\/03602530903491881","article-title":"Sandwich-cultured hepatocytes: An in vitro model to evaluate hepatobiliary transporter-based drug interactions and hepatotoxicity","volume":"42","author":"Swift","year":"2010","journal-title":"Drug Metab. Rev."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1517\/17425255.2013.773973","article-title":"Sandwich-cultured hepatocytes: Utility for in vitro exploration of hepatobiliary drug disposition and drug-induced hepatotoxicity","volume":"9","author":"Chatterjee","year":"2013","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1517\/17425255.2013.759210","article-title":"Model-based approaches to predict drug-drug interactions associated with hepatic uptake transporters: Preclinical, clinical and beyond","volume":"9","author":"Barton","year":"2013","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1124\/dmd.108.025775","article-title":"Assessing the metabolic competence of sandwich-cultured mouse primary hepatocytes","volume":"37","author":"Mathijs","year":"2009","journal-title":"Drug Metab. Dispos."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.tiv.2015.03.019","article-title":"Polarized location of SLC and ABC drug transporters in monolayer-cultured human hepatocytes","volume":"29","author":"Jouan","year":"2015","journal-title":"Toxicology In Vitro"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1124\/dmd.111.042275","article-title":"Absolute quantification and differential expression of drug transporters, cytochrome P450 enzymes, and UDP-glucuronosyltransferases in cultured primary human hepatocytes","volume":"40","author":"Schaefer","year":"2012","journal-title":"Drug Metab. Dispos."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1021\/mp500002y","article-title":"Multilayer spheroids to quantify drug uptake and diffusion in 3D","volume":"11","author":"Achilli","year":"2014","journal-title":"Mol. Pharm."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1146\/annurev.pharmtox.44.101802.121856","article-title":"Transporters and renal drug elimination","volume":"44","author":"Lee","year":"2004","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1146\/annurev-pharmtox-011112-140317","article-title":"Renal transporters in drug development","volume":"53","author":"Morrissey","year":"2013","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1146\/annurev.physiol.64.081501.155913","article-title":"Molecular aspects of renal anionic drug transport","volume":"64","author":"Russel","year":"2002","journal-title":"Annu. Rev. Physiol."},{"key":"ref_176","first-page":"447","article-title":"Renal drug transporters and nephrotoxicity","volume":"14","author":"Anzai","year":"2007","journal-title":"AATEX J."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1097\/01.ASN.0000143473.64430.AC","article-title":"Contribution of multidrug resistance protein 2 (MRP2\/ABCC2) to the renal excretion of p-aminohippurate (PAH) and identification of MRP4 (ABCC4) as a novel PAH transporter","volume":"15","author":"Smeets","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.lfs.2004.06.015","article-title":"Effects of grapefruit juice on the multidrug transporter P-glycoprotein in the human proximal tubular cell line HK-2","volume":"76","author":"Romiti","year":"2004","journal-title":"Life Sci."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/sj.bjp.0706778","article-title":"Modulation of P-glycoprotein activity by cannabinoid molecules in HK-2 renal cells","volume":"148","author":"Nieri","year":"2006","journal-title":"Bri. J. Pharmacol."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/ki.1994.6","article-title":"HK-2: An immortalized proximal tubule epithelial cell line from normal adult human kidney","volume":"45","author":"Ryan","year":"1994","journal-title":"Kidney Int."},{"key":"ref_181","first-page":"281","article-title":"Kidney proximal human tubule HK-2 cell line as a tool for the investigation of P-glycoprotein modulation by natural compounds","volume":"7","author":"Chieli","year":"2008","journal-title":"Bol. Latinoam. Caribe Plantas Med. Aromat."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1021\/mp060037b","article-title":"Characterization of monocarboxylate transport in human kidney HK-2 cells","volume":"3","author":"Wang","year":"2006","journal-title":"Mol. Pharm."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s00424-012-1163-2","article-title":"The limitations of renal epithelial cell line HK-2 as a model of drug transporter expression and function in the proximal tubule","volume":"464","author":"Jenkinson","year":"2012","journal-title":"Pflugers Arch. Eur. J. Physiol."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1081\/JDI-100104717","article-title":"P-glycoprotein in HK-2 proximal tubule cell line","volume":"23","author":"Tramonti","year":"2001","journal-title":"Ren. Fail."},{"key":"ref_185","first-page":"2729","article-title":"Involvement of ABC transporters in chemosensitivity of human renal cell carcinoma, and regulation of MRP2 expression by conjugated bilirubin","volume":"25","author":"Nomura","year":"2005","journal-title":"Anticancer Res."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1124\/dmd.31.12.1507","article-title":"Modeling of intestinal drug absorption: Roles of transporters and metabolic enzymes (for the Gillette Review Series)","volume":"31","author":"Pang","year":"2003","journal-title":"Drug Metab. Dispos."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1146\/annurev-pharmtox-011112-140309","article-title":"Hepatic and intestinal drug transporters: Prediction of pharmacokinetic effects caused by drug-drug interactions and genetic polymorphisms","volume":"53","author":"Yoshida","year":"2013","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ctrv.2008.09.004","article-title":"The biological and clinical role of drug transporters at the intestinal barrier","volume":"35","author":"Oostendorp","year":"2009","journal-title":"Cancer Treat. Rev."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1124\/mol.112.084517","article-title":"Organic cation transporter 1 (OCT1\/mOct1) is localized in the apical membrane of Caco-2 cell monolayers and enterocytes","volume":"84","author":"Han","year":"2013","journal-title":"Mol. Pharmacol."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1124\/dmd.115.068809","article-title":"Human Intestinal PEPT1 Transporter Expression and Localization in Preterm and Term Infants","volume":"44","author":"Mooij","year":"2016","journal-title":"Drug Metab. Dispos."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0300-483X(02)00296-2","article-title":"Transporters and xenobiotic disposition","volume":"181\u2013182","author":"Kim","year":"2002","journal-title":"Toxicology"},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1124\/dmd.107.014902","article-title":"Expression of thirty-six drug transporter genes in human intestine, liver, kidney, and organotypic cell lines","volume":"35","author":"Hilgendorf","year":"2007","journal-title":"Drug Metab. Dispos."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1517\/17425255.4.7.923","article-title":"Intestinal efflux transporters and drug absorption","volume":"4","author":"Murakami","year":"2008","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.1002\/jps.22632","article-title":"Interactions between organic anions on multiple transporters in Caco-2 cells","volume":"100","author":"Grandvuinet","year":"2011","journal-title":"J. Pharm. Sci."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.biocel.2011.12.009","article-title":"Intracellular trafficking of P-glycoprotein","volume":"44","author":"Fu","year":"2012","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1007\/s11095-012-0942-y","article-title":"Role of drug efflux and uptake transporters in atazanavir intestinal permeability and drug-drug interactions","volume":"30","author":"Kis","year":"2013","journal-title":"Pharm. Res."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1515\/hsz-2016-0259","article-title":"Expression, regulation and function of intestinal drug transporters: An update","volume":"398","author":"Muller","year":"2017","journal-title":"Biol. Chem."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1007\/s11095-005-6810-2","article-title":"Apical\/basolateral surface expression of drug transporters and its role in vectorial drug transport","volume":"22","author":"Ito","year":"2005","journal-title":"Pharm. Res."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"235","DOI":"10.2165\/00003088-200241040-00001","article-title":"The mucosa of the small intestine: How clinically relevant as an organ of drug metabolism?","volume":"41","author":"Doherty","year":"2002","journal-title":"Clin. Pharmacokinet."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0002-9440(10)64794-3","article-title":"The effect of rifampin treatment on intestinal expression of human MRP transporters","volume":"157","author":"Fromm","year":"2000","journal-title":"Am. J. Pathol."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ejps.2016.08.054","article-title":"A new mechanism for increasing the oral bioavailability of scutellarin with Cremophor EL: Activation of MRP3 with concurrent inhibition of MRP2 and BCRP","volume":"93","author":"Xiao","year":"2016","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1124\/jpet.108.140475","article-title":"Increasing systemic exposure of methotrexate by active efflux mediated by multidrug resistance-associated protein 3 (mrp3\/abcc3)","volume":"327","author":"Kitamura","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1124\/dmd.111.041731","article-title":"Oral availability of cefadroxil depends on ABCC3 and ABCC4","volume":"40","author":"Kunne","year":"2012","journal-title":"Drug Metab. Dispos."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2174\/1389200043489144","article-title":"Intestinal drug transporters: In vivo function and clinical importance","volume":"5","author":"Kunta","year":"2004","journal-title":"Curr. Drug Metab."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s10565-012-9228-8","article-title":"The effect of oxidative stress upon the intestinal uptake of folic acid: In vitro studies with Caco-2 cells","volume":"28","author":"Couto","year":"2012","journal-title":"Cell Biol. Toxicol."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"414","DOI":"10.2133\/dmpk.21.414","article-title":"Induction of human P-glycoprotein in Caco-2 cells: Development of a highly sensitive assay system for P-glycoprotein-mediated drug transport","volume":"21","author":"Shirasaka","year":"2006","journal-title":"Drug Metab. Pharmacokinet."},{"key":"ref_207","unstructured":"Zweibaum, A., Laburthe, M., Grasset, E., and Louvard, D. (1991). Intestinal absorption and secretion. Handbook of Physiolgy, Oxford University Press."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1124\/dmd.107.015321","article-title":"Permeability, transport, and metabolism of solutes in Caco-2 cell monolayers: A theoretical study","volume":"36","author":"Sun","year":"2008","journal-title":"Drug Metab. Dispos."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.taap.2005.05.004","article-title":"Validation of in vitro cell models used in drug metabolism and transport studies; genotyping of cytochrome P450, phase II enzymes and drug transporter polymorphisms in the human hepatoma (HepG2), ovarian carcinoma (IGROV-1) and colon carcinoma (CaCo-2, LS180) cell lines","volume":"211","author":"Brandon","year":"2006","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1023\/A:1018825819249","article-title":"Evidence for different ABC-transporters in Caco-2 cells modulating drug uptake","volume":"16","author":"Gutmann","year":"1999","journal-title":"Pharm. Res."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0022-3565(24)29314-9","article-title":"Correlation of gene expression of ten drug efflux proteins of the ATP-binding cassette transporter family in normal human jejunum and in human intestinal epithelial Caco-2 cell monolayers","volume":"299","author":"Taipalensuu","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1517\/17425255.1.2.175","article-title":"Caco-2 cell permeability assays to measure drug absorption","volume":"1","author":"Li","year":"2005","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3389\/fphar.2013.00079","article-title":"Alternative functional in vitro models of human intestinal epithelia","volume":"4","author":"Kauffman","year":"2013","journal-title":"Front. Pharmacol."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0169-409X(02)00170-9","article-title":"In vitro and in vivo models for assessing drug efflux transporter activity","volume":"55","author":"Zhang","year":"2003","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2174\/1567201043480036","article-title":"The role of ABC transporters in drug resistance, metabolism and toxicity","volume":"1","author":"Glavinas","year":"2004","journal-title":"Curr. Drug Deliv."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1517\/17425255.4.6.721","article-title":"Utilization of membrane vesicle preparations to study drug-ABC transporter interactions","volume":"4","author":"Glavinas","year":"2008","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"8986","DOI":"10.1016\/S0021-9258(17)37065-5","article-title":"Covalent inhibitors of P-glycoprotein ATPase activity","volume":"269","author":"Urbatsch","year":"1994","journal-title":"J. Biol. Chem."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1373\/49.2.230","article-title":"Real-time reverse transcription-PCR expression profiling of the complete human ATP-binding cassette transporter superfamily in various tissues","volume":"49","author":"Langmann","year":"2003","journal-title":"Clin. Chem."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"686","DOI":"10.2174\/138920111795163931","article-title":"Advances in the molecular detection of ABC transporters involved in multidrug resistance in cancer","volume":"12","author":"Gillet","year":"2011","journal-title":"Curr. Pharm. Biotechnol."},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1093\/clinchem\/46.8.1221","article-title":"Flow cytometry: Principles and clinical applications in hematology","volume":"46 Pt. 2","author":"Brown","year":"2000","journal-title":"Clin. Chem."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/bfgp\/elm011","article-title":"The flow of cytometry into systems biology","volume":"6","author":"Nolan","year":"2007","journal-title":"Brief. Funct. Genom. Proteom."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.vascn.2010.11.003","article-title":"Rapid detection of ABC transporter interaction: Potential utility in pharmacology","volume":"63","author":"Robey","year":"2011","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"ref_223","first-page":"912","article-title":"P-glycoprotein activity in human Caucasian male lymphocytes does not follow its increased expression during aging","volume":"79","author":"Silva","year":"2011","journal-title":"Cytometry A"},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.cbi.2014.04.009","article-title":"Colchicine effect on P-glycoprotein expression and activity: In silico and in vitro studies","volume":"218","author":"Silva","year":"2014","journal-title":"Chem. Biol. Interact."},{"key":"ref_225","doi-asserted-by":"crossref","unstructured":"Lebedeva, I.V., Pande, P., and Patton, W.F. (2011). Sensitive and specific fluorescent probes for functional analysis of the three major types of mammalian ABC transporters. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0022429"},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"46","DOI":"10.18433\/J3RC77","article-title":"Emerging significance of flavonoids as P-glycoprotein inhibitors in cancer chemotherapy","volume":"12","author":"Bansal","year":"2009","journal-title":"J. Pharm. Pharm. Sci."},{"key":"ref_227","first-page":"177","article-title":"Inhibition of P-glycoprotein expression and function by anti-diabetic drugs gliclazide, metformin, and pioglitazone in vitro and in situ","volume":"11","author":"Abbasi","year":"2016","journal-title":"Res. Pharm. Sci."},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"5774","DOI":"10.2174\/1381612822666160810114008","article-title":"Design and Synthesis of New Selective P-gp Substrates and Inhibitors","volume":"22","author":"Cantore","year":"2016","journal-title":"Curr. Pharm. Des."},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ijpharm.2016.02.022","article-title":"Prediction and characterization of P-glycoprotein substrates potentially bound to different sites by emerging chemical pattern and hierarchical cluster analysis","volume":"502","author":"Pan","year":"2016","journal-title":"Int. J. Pharm."},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.canlet.2015.10.010","article-title":"Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: A review of the past decade","volume":"370","author":"Chen","year":"2016","journal-title":"Cancer Lett."},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1208\/s12248-014-9628-1","article-title":"An electrically tight in vitro blood-brain barrier model displays net brain-to-blood efflux of substrates for the ABC transporters, P-gp, Bcrp and Mrp-1","volume":"16","author":"Helms","year":"2014","journal-title":"AAPS J."},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1023\/A:1023895404929","article-title":"Apparent lack of Mrp1-mediated efflux at the luminal side of mouse blood-brain barrier endothelial cells","volume":"20","author":"Cisternino","year":"2003","journal-title":"Pharm. Res."},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ymeth.2005.11.007","article-title":"Western blotting","volume":"38","author":"Kurien","year":"2006","journal-title":"Methods"},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.bcp.2010.12.018","article-title":"Breast cancer resistance protein BCRP\/ABCG2 regulatory microRNAs (hsa-miR-328, -519c and -520h) and their differential expression in stem-like ABCG2+ cancer cells","volume":"81","author":"Li","year":"2011","journal-title":"Biochem. Pharmacol."},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.bcp.2010.10.006","article-title":"Acetaminophen-induced stimulation of MDR1 expression and activity in rat intestine and in LS 174T human intestinal cell line","volume":"81","author":"Ghanem","year":"2011","journal-title":"Biochem. Pharmacol."},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1038\/nprot.2007.303","article-title":"Determination of drug permeability and prediction of drug absorption in Caco-2 monolayers","volume":"2","author":"Hubatsch","year":"2007","journal-title":"Nat. Protoc."},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ejps.2008.11.005","article-title":"In vitro-in vivo correlation in P-glycoprotein mediated transport in intestinal absorption","volume":"36","author":"Heikkinen","year":"2009","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1046\/j.1365-2362.33.s2.4.x","article-title":"Importance of P-glycoprotein for drug disposition in humans","volume":"33","author":"Fromm","year":"2003","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2165\/00003088-200342010-00003","article-title":"Role of P-glycoprotein in pharmacokinetics: Clinical implications","volume":"42","author":"Lin","year":"2003","journal-title":"Clin. Pharmacokinet."},{"key":"ref_240","first-page":"RA5","article-title":"Multidrug resistance P-glycoprotein: Crucial significance in drug disposition and interaction","volume":"10","author":"Sun","year":"2004","journal-title":"Med. Sci. Monit."},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.nut.2015.01.003","article-title":"Fructose-induced metabolic syndrome decreases protein expression and activity of intestinal P-glycoprotein","volume":"31","author":"Novak","year":"2015","journal-title":"Nutrition"},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"3830","DOI":"10.1002\/jps.23673","article-title":"Acetaminophen inhibits intestinal p-glycoprotein transport activity","volume":"102","author":"Novak","year":"2013","journal-title":"J. Pharm. Sci."},{"key":"ref_243","doi-asserted-by":"crossref","unstructured":"Zhang, Y.-K., Zhang, X.-Y., Zhang, G.-N., Wang, Y.-J., Xu, H., Zhang, D., Shukla, S., Liu, L., Yang, D.-H., Ambudkar, S.V., and Chen, Z.-S. Selective reversal of BCRP-mediated MDR by VEGFR-2 inhibitor ZM323881. Biochem. Pharmacol., 2017.","DOI":"10.1016\/j.bcp.2017.02.019"},{"key":"ref_244","doi-asserted-by":"crossref","unstructured":"L\u00e1szl\u00f3, L., Sarkadi, B., and Heged\u0171s, T. (2016). Jump into a new fold\u2014A homology based model for the ABCG2\/BCRP multidrug transporter. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0164426"},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2174\/1568009616666160901094140","article-title":"Grid-independent Descriptors (GRIND) analysis and SAR guided molecular docking studies to probe selectivity profiles of inhibitors of multidrug resistance transporters ABCB1 and ABCG2","volume":"17","author":"Talha","year":"2017","journal-title":"Curr. Cancer Drug Targets"},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"15494","DOI":"10.18632\/oncotarget.3820","article-title":"Trametinib modulates cancer multidrug resistance by targeting ABCB1 transporter","volume":"6","author":"Qiu","year":"2015","journal-title":"Oncotarget"},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"13","DOI":"10.6026\/97320630008013","article-title":"In vitro and In silico studies on inhibitory effects of curcumin on multi drug resistance associated protein (MRP1) in retinoblastoma cells","volume":"8","author":"Sreenivasan","year":"2012","journal-title":"Bioinformation"},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1248\/bpb.31.2068","article-title":"Comparison of Inducibility of Multidrug Resistance (MDR)1, Multidrug Resistance-Associated Protein (MRP)1, and MRP2 mRNAs by prototypical microsomal enzyme inducers in primary cultures of human and cynomolgus monkey hepatocytes","volume":"31","author":"Nishimura","year":"2008","journal-title":"Biol. Pharm. Bull."},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2133\/dmpk.21.297","article-title":"Regulation of mRNA expression of MDR1, MRP1, MRP2 and MRP3 by prototypical microsomal enzyme inducers in primary cultures of human and rat hepatocytes","volume":"21","author":"Nishimura","year":"2006","journal-title":"Drug Metab. Pharmacokinet."},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0300-483X(01)00570-4","article-title":"Influence of redox-active compounds and PXR-activators on human MRP1 and MRP2 gene expression","volume":"171","author":"Kauffmann","year":"2002","journal-title":"Toxicology"},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0378-4274(01)00306-X","article-title":"Up-regulation of transporters of the MRP family by drugs and toxins","volume":"120","author":"Schrenk","year":"2001","journal-title":"Toxicol. Lett."},{"key":"ref_252","first-page":"1339","article-title":"Mouse breast cancer resistance protein (Bcrp1\/Abcg2) mediates etoposide resistance and transport, but etoposide oral availability is limited primarily by P-glycoprotein","volume":"63","author":"Allen","year":"2003","journal-title":"Cancer Res."},{"key":"ref_253","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.brainres.2016.10.020","article-title":"Phytochemical mediated-modulation of the expression and transporter function of breast cancer resistance protein at the blood-brain barrier: An in vitro study","volume":"1654","author":"Kaur","year":"2017","journal-title":"Brain Res."},{"key":"ref_254","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3109\/00498254.2014.955831","article-title":"Evaluation of 309 molecules as inducers of CYP3A4, CYP2B6, CYP1A2, OATP1B1, OCT1, MDR1, MRP2, MRP3 and BCRP in cryopreserved human hepatocytes in sandwich culture","volume":"45","author":"Badolo","year":"2015","journal-title":"Xenobiotica"},{"key":"ref_255","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1124\/dmd.106.010033","article-title":"Differential regulation of sinusoidal and canalicular hepatic drug transporter expression by xenobiotics activating drug-sensing receptors in primary human hepatocytes","volume":"34","author":"Jigorel","year":"2006","journal-title":"Drug Metab. Dispos."},{"key":"ref_256","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/carcin\/bgi139","article-title":"Identification of BCRP as transporter of benzo[a]pyrene conjugates metabolically formed in Caco-2 cells and its induction by Ah-receptor agonists","volume":"26","author":"Ebert","year":"2005","journal-title":"Carcinogenesis"},{"key":"ref_257","doi-asserted-by":"crossref","first-page":"747","DOI":"10.4161\/cbt.4.7.1826","article-title":"Chronic imatinib mesylate exposure leads to reduced intracellular drug accumulation by induction of the ABCG2 (BCRP) and ABCB1 (MDR1) drug transport pumps","volume":"4","author":"Burger","year":"2005","journal-title":"Cancer Biol. Ther."},{"key":"ref_258","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1016\/j.bcp.2010.08.016","article-title":"A novel xenobiotic responsive element regulated by Aryl Hydrocarbon Receptor is involved in the induction of BCRP\/ABCG2 in LS174T cells","volume":"80","author":"Tompkins","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"ref_259","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/toxsci\/kfl147","article-title":"Phytochemicals induce breast cancer resistance protein in Caco-2 cells and enhance the transport of Benzo[a]pyrene-3-sulfate","volume":"96","author":"Ebert","year":"2007","journal-title":"Toxicol. Sci."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/22\/4\/600\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T18:32:16Z","timestamp":1760207536000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/22\/4\/600"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,8]]},"references-count":259,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2017,4]]}},"alternative-id":["molecules22040600"],"URL":"https:\/\/doi.org\/10.3390\/molecules22040600","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,8]]}}}